NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
83 hedge funds and large institutions have $35.5M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
Holders
83
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$903K | |
| 2 | +$201K | |
| 3 | +$183K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$125K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$115K |
Top Sellers
| 1 | -$3.48M | |
| 2 | -$1.19M | |
| 3 | -$568K | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$535K |
| 5 |
JRP
Jasper Ridge Partners
Menlo Park,
California
|
-$244K |